Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Tune Therapeutics — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
Watch the 2-minute tour · with sound

Tune Therapeutics raised over $175M in Series B financing led by New Enterprise Associates, Yosemite, Regeneron Ventures, and Hevolution Foundation to advance its epigenome editing programs.

PRIVATEJan 13, 2025over 1 year ago

Amount Raised

$175 Million

Round Type

series b

Investors

Hevolution FoundationRegeneron VenturesYosemiteNew Enterprise Associates

Description

Tune Therapeutics has completed over $175M in Series B financing, which will accelerate the development of its existing pipeline and support new gene, cell, and regenerative therapy programs. The funding is aimed at advancing their clinical-stage drug for chronic Hepatitis B and other epigenetic therapies.

Company Information

Company

Tune Therapeutics

About

Tune Therapeutics aims to bring gene, cell, and regenerative therapies into a new era of human medicine – expanding their range of application to common, chronic and age-related diseases that are straining healthcare systems and limiting human healthspan on a global scale.

Predictive Intelligence
Strategic

ML-powered predictions for Tune Therapeutics's next move

Learn about Strategic plan

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Tune Therapeutics? See every signal — funding, hires, M&A, contracts, sentiment.

See plans